Mesoblast Limited ( MESO) - Stock Earnings

MESO Quarterly earnings

DateEarningsRevenue
2024Q4 -24.0 million USD 1.6 million USD
2025Q1 -27.1 million USD 7.0 million USD
2025Q2 -27.1 million USD 7.0 million USD

MESO Yearly earnings

DateEarningsRevenue
2023 -81.9 million USD 7.5 million USD
2024 -88.0 million USD 5.9 million USD
2025 -102.1 million USD 17.2 million USD

MESO

Price: $13.94

52 week price:
9.88
21.50

Earnings Per Share: -0.85 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Australia

Volume: 45251

Ebitda: -19.5 million

Market Capitalization: 1.8 billion

Links: